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Gnathostomiasis is a foodborne zoonotic helminthic 
infection caused by the third-stage larvae of Gnathostoma 
spp. nematodes. The most severe manifestation involves 
infection of the central nervous system, neurognathostomiasis. 
Although gnathostomiasis is endemic to Asia and Latin 
America, almost all neurognathostomiasis cases are 
reported from Thailand. Despite high rates of illness and 
death, neurognathostomiasis has received less attention 
than the more common cutaneous form of gnathostomiasis, 
possibly because of the apparent geographic conﬁ  nement 
of the neurologic infection to 1 country. Recently, however, 
the disease has been reported in returned travelers in 
Europe. We reviewed the English-language literature on 
neurognathostomiasis and analyzed epidemiology and 
geographic distribution, mode of central nervous system 
invasion, pathophysiology, clinical features, neuroimaging 
data, and treatment options. On the basis of epidemiologic 
data, clinical signs, neuroimaging, and laboratory ﬁ  ndings, 
we propose diagnostic criteria for neurognathostomiasis.
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F
oodborne parasitic infections are common in the 
tropics, where many foodborne parasites are endemic 
and ingestion of raw shellﬁ  sh and freshwater ﬁ  sh, as well 
as undercooked meat, is frequent among local populations 
(1). Increased international travel to areas endemic for 
these foodborne parasites and migration from tropical areas 
have led to the emergence of these diseases in temperate 
climates (2), where such infections are rarely seen by 
physicians and thus may not be considered in differential 
diagnoses. Gnathostomiasis is a foodborne zoonotic 
helminthic infection caused by the third-stage larva of 
Gnathostoma spp. nematodes (Figure 1, panels A, B). At 
least 13 species have been identiﬁ  ed (3), with 5 recorded 
in humans. G. spinigerum is the most common of these 
nematodes in Asia. Human infection with G. hispidum, 
G. doloresi, and G. nipponicum were found only in Japan 
(4). In the Americas, G. binucleatum is the only proven 
pathogenic Gnathostoma nematode in humans. Humans are 
infected primarily by eating raw or undercooked freshwater 
ﬁ  sh (Figure 1, panel C), frogs, and chicken. Humans are 
accidental unsuitable hosts; the parasite rarely develops to 
an adult worm, and the disease in humans is caused by the 
migrating larva.
Gnathostomiasis can be divided into cutaneous, 
visceral, and ocular forms, depending on the site of larval 
migration and subsequent signs and symptoms (2). The 
most common clinical presentation is the cutaneous one 
(Figure 1, panel D), which is characterized by localized, 
intermittent, migratory swellings of the skin and is often 
associated with localized pain, pruritus, and erythema 
(5,6). Visceral involvement can manifest in virtually 
any organ and any part of the body (3). The most severe 
manifestation of the visceral disease is involvement of the 
central nervous system (CNS), i.e., neurognathostomiasis. 
Neurognathostomiasis has been reported only in G. 
spinigerum infections (3).
We found 24 reports describing a total of 248 patients 
with neurognathostomiasis published in English-language 
literature. In this article, we review epidemiology, mode 
of CNS invasion, pathophysiology, clinical features, 
neuroimaging data, and treatment options, and we propose 
diagnostic criteria for this emerging disease.
History of Neurognathostomiasis
The  ﬁ   rst clinical case of G. spinigerum menin-
goencephalitis was reported by Daensvang in 1949 
(7). Eighteen years later, Chitanondh and Rosen (8) 
documented the ﬁ  rst pathologic evidence of G. spinigerum 
invasion of the CNS from the autopsy of a 34-year-old 
Thai woman. In their seminal study, Boongird et al. (9) 
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Figure 1. A) Third-stage larva of the 
nematode  Gnathostoma sp. Scale 
bar = 250 μm. B) Scanning electronic 
microscopy image depicting head bulb 
with 4 cephalic hooklet rows. Original 
magniﬁ  cation ×500. C) Gnathostoma sp. 
larvae in the ﬂ  esh of their intermediate host, 
Eleotris picta ﬁ  sh. Original magniﬁ  cation 
×4. Inset: Higher magniﬁ   cation of an 
encysted larva; original magniﬁ  cation 
×100. Larvae photographs courtesy of Dr 
Diaz-Camacho, Universidad Autónoma 
de Sinaloa, Sinaloa, Mexico. D) Cross-
section of a Gnathostoma sp. larva in 
human skin biopsy sample (hematoxylin 
and eosin stain). Scale bar = 250 μm.SYNOPSIS
delineated the clinical syndromes of neurognathostomiasis, 
which facilitated further prospective and retrospective case 
identiﬁ  cation  (10). With the advance of high-resolution 
neuroimaging, the parasitic tracks of Gnathostoma could 
be demonstrated on magnetic resonance imaging (MRI), 
aiding the diagnosis of neurognathostomiasis in the absence 
of worm recovery (11).
Epidemiology of Neurognathostomiasis
Most (241/248) identiﬁ   ed cases of neurognathosto-
miasis reported in the English-language literature were 
from Thailand. Two patients were infected in Laos (12,13), 
1 in Japan (14), 1 in Myanmar (13), and 2 in South Korea 
(15,16). One patient had traveled to Southeast Asia and Japan 
(17), so the geographic origin of his infection could not be 
determined. The incubation period of neurognathostomiasis 
can be as long as 10 years because of the long persistence of 
the nematode larvae in the soft tissues before CNS invasion 
(2,15), which means it can occur in immigrants in a country 
in which the parasite is not endemic (16,18). All case-
patients were reported to be infected with G. spinigerum. 
Although gnathostomiasis has been increasingly detected 
outside of Asia, particularly in Mexico, no cases of 
neurognathostomiasis have been reported in other regions. 
The occurrence of another Gnathostoma species in Latin 
America, namely G. binucleatum, is a possible explanation 
for this phenomenon.
Neurognathostomiasis in Travelers
The ﬁ  rst case of neurognathostomiasis in a traveler 
was reported in 2003 (19). Since then, 4 patients in Europe 
returning from gnathostomiasis-endemic countries have 
been published (13,20,21). Two patients traveled to 
Thailand (19,20), 1 patient to Lao People’s Democratic 
Republic (13) and 1 patient to Myanmar (13). The patients 
were reported to have indulged in local customs of eating 
raw ﬁ  sh (19) and shrimp (20). Gnathostomiasis has been 
recently reported in travelers returning from southern 
Africa (22,23). However, the patients had cutaneous 
manifestation of Gnathostoma  spp. infection without 
neurologic involvement.
Pathophysiology of Neurognathostomiasis
Gnathostoma spp. nematodes are highly invasive 
parasites. After being ingested, the third-stage larvae 
penetrate the mucosal wall of the gastrointestinal tract. 
Larvae can enter the CNS by invading directly through 
the loose connective tissues of the neural foramina of the 
skull base along the cranial nerves and vessels or through 
intervertebral foramina along the spinal nerves and vessels 
(24). The larvae release a variety of molecules into their 
surrounding environment that facilitate tissue penetration 
and invasion (25). Proteases are the major molecular types 
among various components of these so-called excretor–
secretory products, both quantitatively and qualitatively 
(26). In Gnathostoma spp., matrix metalloproteinases 
might play a key role in invasion of host tissues (27).
Gnathostoma spp. nematodes typically enter the spinal 
cord along the nerve roots, causing radiculomyelitis (9,28). 
The parasite is then able to ascend the spinal cord and reach 
the brain (3,29). This journey may take as long as several 
years and has been documented in a Thai patient through 
sequential imaging (29).
Given the length of the migrating larva, which 
averages 3.0 mm (30), the migration of the worm in the 
CNS causes direct mechanical injury because of tearing of 
nerve tissue. The hallmark sign of neurognathostomiasis is 
the evidence of multiple hemorrhagic tracks; these tracks 
have been documented throughout the spinal cord and 
brain tissue by postmortem examination (9), as well as 
through neuroimaging (31). Subarachnoid hemorrhage can 
result from larvae burrowing through a cerebral arteriole 
(32,33). Eosinophilic meningitis caused by Gnathostoma 
spp. is characterized by erythrocytes in cerebrospinal ﬂ  uid 
(CSF) (33), which suggests mechanical damage by the 
worm. Apart from the structural damage, the inﬂ  ammatory 
response to the migrating larvae might further contribute to 
tissue destruction (34).
Clinical Signs of Neurologic Involvement
The main clinical syndromes of neurognathostomiasis 
are radiculomyelitis/ radiculomyeloencephalitis, menin-
gitis/meningoencephalitis, and subarachnoid and 
intracerebral hemorrhage (Table 1). Each syndrome 
reﬂ  ects the tissue injury by the migrating parasite. Because 
the larvae migrate, the same patient can show sequentially 
different neurologic syndromes. For example, in 1 
Laotian patient, meningomyelitis developed, followed 
by subarachnoid hemorrhage (12). Meningitis, subdural 
hemorrhage, and then intraparenchymal lesions developed 
sequentially in 1 patient from northeastern Thailand 
(29). The most common symptom reported virtually by 
every patient was pain: radicular pain in cases of spinal 
involvement (often lasting 1–5 days) or headache in cases 
of meningoencephalitis. The most common manifestation, 
spinal cord disease, accounted for 55% of all clinical 
syndromes (Table 1).
Myelopathy in gnathostomiasis is characterized by 
radicular pain followed by an ascending paresis of lower 
extremities or quadriparesis with bladder dysfunction 
(9,10,33,35–38). A sensory level for all modalities 
including vibration and proprioception was a frequent 
ﬁ   nding, commonly localized in the thoracic region (9). 
Cerebral and meningeal involvement is characterized by 
meningeal signs and decreased consciousness. Abducens 
nerve palsy was the most common cranial nerve impairment 
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(9,33). Intracranial hemorrhages were seen with sudden-
onset focal neurologic deﬁ   cits such as hemiparesis and 
hemihypaesthesia (9,10,18,33).
Isolated Neurologic Disease
The most common clinical feature of gnathostomiasis 
is intermittent migratory cutaneous swelling (5). However, 
in the largest published series of neurognathostomiasis 
in 162 patients, only 11 (7%) had a history of cutaneous 
lesions (10). Unilateral eyelid swelling, another typical sign 
of gnathostomiasis, occurred in only 6 patients (4%) (10). 
Boongird et al. reported only 3 patients with subcutaneous 
swelling out of 24 patients with neurognathostomiasis; 
cutaneous gnathostomiasis developed in all of these 
patients after the onset of neurologic symptoms (9).
CSF Studies
Eosinophilic pleocytosis is a hallmark laboratory 
ﬁ  nding. CSF eosinophilia in patients is usually prominent; 
median values were 40% (n = 24) and 54% (n = 39) in 
the studies by Boongird et al (9) and Schmutzhard et al 
(33), respectively. In 109 (67%) of patients reported by 
Punyagupta et al. (10), the eosinophil count in CSF was 
>30%. CSF has been reported as xanthochromic or bloody 
in 134 patients (64% of all published cases). CSF glucose is 
usually only mildly reduced but was reported as low as 11 
mg/dL (9% of the plasma value) in 1 patient (37).
Neuroradiologic Features
Neuroimaging of 11 patients with neurognathostomiasis 
was reported in English-language literature. On cranial 
computed tomography, subarachnoid hemorrhage and 
intracerebral hemorrhage were the most common ﬁ  ndings 
(12,18,33). In 1 patient a subdural hemorrhage was 
detected (29). The hallmark of cerebral gnathostomiasis 
on MRI was the detection of hemorrhagic tracks (Figure 
2, panels A, C, D). The magnetic resonance signal of 
a hemorrhagic lesion varies in acute, subacute, and 
chronic lesions. Hence, on T1 and T2 weighted imaging 
both hypointensities and hyperintensities have been 
documented. No gradient-echo T2-weighted sequences 
have been reported in neurognathostomiasis. However, 
gradient-echo T2-weighted sequences are exquisitely 
sensitive to local ﬁ  eld inhomogeneities of hematoma and 
could become a useful sequence in radiologic assessment 
of cerebral gnathostomiasis.
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Table 1. Clinical presentation of 248 patients with neurognathostomiasis* 
Syndrome  Probable entry portal entry  Clinical signs and symptoms  No. (%) cases 
Radiculomyelitis/myelitis/ 
myeloencephalitis 
Intervertebral foramina along the 
spinal nerves and vessels 
Sharp radicular pain and a spinal syndrome 
(paraplegia, monoplegia, quadriplegia, bladder 
dysfunction, sensory disturbances), can progress to 
cerebral involvement (myeloencephalitis) 
140 (55) 
Meningitis/
meningoencephalitis 
Neural foramina of the skull base 
along the cranial nerves and 
vessels 
Severe headache, stiffness of the neck, cranial nerve 
palsies, disturbance of consciousness, focal 
neurologic signs 
77 (30) 
Intracerebral hemorrhage  Intervertebral or neural foramina  Headache, sudden-onset focal neurologic signs  21 (8) 
Subarachnoid hemorrhage  Intervertebral or neural foramina  Thunderclap headache, meningeal signs  16 (7) 
*Because the larvae migrate, patients can have sequential signs and symptoms; thus, the total number of clinical syndromes shown
exceeds the number of reported patients. 
Figure 2. Images of the brains of patients with cerebral gnathostomiasis. A) Axial T1-weighted image showing small hemorrhage in the 
right basal ganglia (arrow). B) Sagittal T2-weighted images showing diffuse cord enlargement with longitudinal T2 hyperintensity (arrows). 
C) Axial T1-weighted image showing a hemorrhagic track in the tegmentum of the pons (arrow). D) Coronal T1-weighted postgadolinium 
image, showing the longitudinal extension of the same hemorrhagic track as in panel C (arrows). Images from K. Sawanyawisuth et al. 
(11), used with permission.SYNOPSIS
Diffuse multisegmental spinal cord swelling with 
corresponding T2 hyperintensities was the most common 
ﬁ   nding on spinal imaging (11,17) (Figure 2, panel B). 
Gadolinium enhancement of the lesions was reported in 
cranial and spinal MRI of 4 patients as slight, nodular, and 
ill-deﬁ  ned (11,17,35). Table 2 summarizes typical ﬁ  ndings 
on neuroimaging in neurognathostomiasis.
Immunodiagnosis
The detection of antibodies in serum is the main pillar 
of immunodiagnosis of gnathostomiasis. Two methods have 
been established for clinical routine: ELISA and Western 
blot by using crude Gnathostoma spp. antigens from the 
larval extract. The 24-kD band on Western blot was shown 
to have nearly 100% speciﬁ  city for gnathostomiasis (39). 
The current practice for serologic diagnosis is to use the 
ELISA (e.g., multiple-dot ELISA) as the ﬁ  rst step (40) and 
to conﬁ  rm the results by Western blot. At least 2 patients 
seroconverted during their neurologic illness (19,20), which 
emphasizes the need for repeated serologic examination in 
cases with strong clinical suspicion. The serologic testing 
can be done in several laboratories, including those in 
Thailand (Bangkok, Khon Kaen), Japan (Miayzaki), and 
Europe (Basel, Switzerland). Additional information about 
laboratories providing this service is available from the 
corresponding author.
Differential Diagnosis
The main differential diagnosis of neurognat-
hostomiasis is an infection with Angiostrongylus 
cantonensis. However, Angiostrongylus spp. infection is 
usually seen as self-limited eosinophilic meningitis and 
only rarely causes severe disease with prominent spinal 
or cerebral involvement (1). Immunodiagnostically, 
positive 24-kD band against G. spinigerum antigen 
and negative 29-kD and 31-kD bands on immunoblot 
against A. cantonensis antigen make a diagnosis of an 
Angiostrongylus spp. infection highly unlikely (40). Other 
causes of a parasitic CNS disease, such as cysticercosis, 
toxocariasis, schistosomiasis, baylisascariasis, or 
paragonimiasis, can be distinguished by epidemiologic 
distribution, clinical signs and symptoms, radiologic 
appearance, and serologic testing.
Treatment
No randomized trials of antihelminthic therapy have 
been conducted for neurognathostomiasis. We have 
identiﬁ  ed 9 reports of treatment of neurognathostomiasis 
with albendazole (11,13,17–21,29); 5 patients fully 
recovered, 2 partially recovered, and 2 patients did not 
recover. Outcomes might reﬂ   ect the natural course of 
the disease rather than the effect of treatment. In several 
reports, antihelminthic treatment was considered as 
potentially detrimental and was withheld on the basis of its 
possible induction of brain edema due to sudden helminthic 
death (31,38). Three returned travelers from Thailand were 
treated with albendazole (800 mg/d for 1 month [19], 
800 mg/d for 3 weeks [20], and 400 mg 2×/d for 4 weeks 
[21]) and fully recovered (19–21). In all these patients, 
dexamethasone (oral or intravenous) or predinsolone was 
added to the treatment regimen. A recent retrospective 
evaluation of long-term treatment efﬁ  cacy in 13 patients 
from France with imported gnathostomiasis reported 2 
patients with neurologic involvement (13), 1 with myelitis, 
and 1 with encephalitis (C. Strady, pers. comm.). The 
patient with myelitis fully recovered after albendazole 
therapy, and the patient with encephalitis was reported to 
have had 4 relapses despite therapy with ivermectin and 
albendazole (13; C. Strady, pers. comm.).
Corticosteroids have been used in neurognathostomiasis 
to treat cerebral and spinal edema (19–21). They also might 
prevent or alleviate paradoxical worsening after initiation 
of antihelminthic treatment. However, no conclusion about 
their efﬁ  cacy can be drawn from the current data because 
no randomized control trials have been conducted and the 
retrospective data are too limited to allow any comparison 
between the groups. At the moment, no evidence-based 
recommendations can be issued.
Outcome
The case-fatality rate in the ﬁ  rst series of 24 patients 
was 25% (9). Later studies reported mortality rates of 7%–
12% (10,33). However, as the authors remark, these case-
fatality rates are almost certainly an underestimate because 
many patients in critical condition were discharged home 
to die (10). In total, the outcome of 247 patients has been 
reported in the literature. An unfavorable outcome, e.g., 
death or severe persistent disability, was reported in 78 
patients (32%). However, the recent case reports indicate 
that the current prognosis might be better. Of 15 patients 
in whom neurognathostomiasis was diagnosed after 2001, 
poor outcomes were reported in 3 (20%) patients. In all 4 
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Table 2. Neuroradiologic features of neurognathostomiasis* 
Site Procedure Findings
Brain CT  Parenchymal (single or multiple), subdural 
or subarachnoid hyperdensities 
corresponding to intracranial hemorrhage 
MRI Multiple (worm-like) T2-weighted 
hyperintensities or hypointensities in both 
hemispheres and the cerebellum of >3 mm 
diameter (hemorrhagic tracks) with or 
without gadolinium enhancement 
Spinal
cord 
MRI Dilatation/swelling of the spinal cord with 
multisegmental T2-weighted 
hyperintensities, frequent gadolinium 
enhancement (slight to moderate) on T1 
postcontrast images 
*CT, computed tomography; MRI, magnetic resonance imaging. Neurognathostomiasis
clinical cases of returned travelers with myelitis, recovery 
was good after antihelminthic therapy (13,19–21).
Conclusions
Deﬁ   nitive diagnosis of helminthic CNS infections 
is notoriously difﬁ  cult. The recovery rate of worms from 
the CSF is low, and the invasive procedures for diagnosis 
are seldom justiﬁ  ed (33,35). Neurognathostomiasis is no 
exception; of 248 published cases, only 27 (11%) were 
conﬁ  rmed by recovery of larvae. Moreover, an intermittent 
subcutaneous swelling, the hallmark of gnathostomiasis, 
is found only in the minority of neurognathostomiasis 
cases. Given these difﬁ  culties, clinical criteria are useful 
for practice and research. On the basis of the analysis of 
published cases, we propose diagnostic criteria that should 
guide a clinician if a pathologic diagnosis is not possible 
(Table 3).
Neurognathostomiasis is a parasitic CNS disease 
endemic to Southeast Asia, particularly Thailand. Because 
of growing international travel to disease-endemic areas, as 
well as migration from the tropics, an increasing number 
of patients will seek medical attention in Europe and North 
America. Neurognathostomiasis should be suspected 
in patients who have eosinophilic radiculomyelitis, 
myeloencephalitis or meningoencephalitis, and a history 
of travel to gnathostomiasis-endemic areas. Ingestion of 
raw or inadequately cooked shellﬁ  sh, freshwater ﬁ  sh, or 
poultry is a prerequisite for infection; however, because 
such information might not be volunteered by the patient, 
clinicians should ask directly about foods eaten during 
travel. Serologic testing, including Western blot, shows 
high speciﬁ   city and can contribute to the diagnosis in 
an appropriate clinical and epidemiologic setting. No 
evidence-based protocol is available for treatment of 
neurognathostomiasis; however, a 3- to 4-week course 
of albendazole with prednisolone or dexamethasone is 1 
of the most frequently used regimens. Clinicians should 
advise patients traveling to or living in disease-endemic 
areas to avoid eating undercooked freshwater ﬁ  sh, frogs, 
poultry, and shellﬁ  sh. 
Dr Katchanov is a neurologist and a member of the Faculty 
of Tropical Medicine, Mahidol University, Bangkok, Thailand. 
He has a special interest in neuroinfectious disorders, particularly 
bacterial meningitis, and neurohelminthiases.
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Table 3. Proposed diagnostic criteria for neurognathostomiasis* 
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  AND exposure to undercooked freshwater fish, frogs, poultry,  
 and  shellfish 
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 OR  intracerebral  hemorrhage 
  OR subarachnoid hemorrhage 
Indirect evidence of CNS invasion 
  CSF studies: eosinophilic pleocytosis 
  OR neuroimaging: parenchymal hemorrhagic tracks (>3 mm) 
Immunodiagnosis
  Positive detection of reactivity against the 24-kDa component  
 of  Gnathostoma spinigerum in immunoblot test† 
  Absence of reactivity against the 29–31-kDa components of  
Angiostrongylus cantonensis in immunoblot test
*All criteria should be fullfiled for clinical diagnosis of 
neurognathostomiasis. CNS, central nervous system; CSF, cerebrospinal 
fluid.  
†If negative, a follow-up examination 4 weeks later is recommended. SYNOPSIS
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